A somatically mutated human antiganglioside IgM antibody that induces experimental neuropathy in mice is encoded by the variable region heavy chain gene, V1-18.

HJ Willison, GM O'Hanlon, G Paterson… - The Journal of …, 1996 - Am Soc Clin Investig
HJ Willison, GM O'Hanlon, G Paterson, J Veitch, G Wilson, M Roberts, T Tang, A Vincent
The Journal of clinical investigation, 1996Am Soc Clin Investig
IgM paraproteins associated with autoimmune peripheral neuropathy and anti-Pr cold
agglutinins react with sialic acid epitopes present on disialylated gangliosides including
GD1b, GT1b, GQ1b, and GD3. A causal relationship between the paraprotein and the
neuropathy has never been proven experimentally. From peripheral blood B cells of an
affected patient, we have cloned a human hybridoma secreting an antidisialosyl IgM mAb,
termed Ha1, that shows identical structural and functional characteristics to its serum …
IgM paraproteins associated with autoimmune peripheral neuropathy and anti-Pr cold agglutinins react with sialic acid epitopes present on disialylated gangliosides including GD1b, GT1b, GQ1b, and GD3. A causal relationship between the paraprotein and the neuropathy has never been proven experimentally. From peripheral blood B cells of an affected patient, we have cloned a human hybridoma secreting an antidisialosyl IgM mAb, termed Ha1, that shows identical structural and functional characteristics to its serum counterpart. Variable region analysis shows Ha1 is encoded by the same VH1 family heavy chain gene, V1-18, as the only other known anti-Pr antibody sequence and is somatically mutated, suggesting that it [correction of is] arose in vivo in response to antigenic stimulation. In the rodent peripheral nervous system, Ha1 immunolocalizes to dorsal root ganglia, motor nerve terminals, muscle spindles, myelinated axons, and nodes of Ranvier. After intraperitoneal injection of affinity-purified antibody into mice for 10 d, electrophysiological recordings from the phrenic nerve-hemidiaphragm preparation demonstrated impairment of nerve excitability and a reduction in quantal release of neurotransmitter. These data unequivocally establish that an antidisialosyl antibody can exert pathophysiological effects on the peripheral nervous system and strongly support the view that the antibody contributes to the associated human disease.
The Journal of Clinical Investigation